|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication January 25, 2006.
Revised January 25, 2006.
Accepted for publication January 25, 2006.
G Protein-coupled receptor (GPCR)-G
fusion proteins were first characterized more than 10 years ago as a strategy for studying receptor-G protein signaling. A large number of studies have used this approach to characterize receptor coupling to members of the Gs, Gi and Gq families of G
subunits, but this strategy has not been widely used to study G
12 and G
13. As described in the article by Zhang et al in this issue of Molecular Pharmacology( Mol Pharmacol ), characterization of the signaling properties of Thromboxane A2 receptor (TP
) -G
12 and -G
13 fusion constructs demonstrates the applicability of this strategy to members of this unique family of G
subunits, and how this strategy can be used to resolve otherwise difficult problems of receptor pharmacology associated with these proteins. The general strategy of making receptor-Ga fusion constructs has wide applicability to a number of research problems, but there are perhaps also "hidden messages" in how different receptor-Ga subunit fusion pairs differ from one another.
Key words:
Prostanoid, G12,13;other G's, G protein regulation, Func. analysis receptor/ion channel mutants, Mutagenesis/Chimeric approaches